D
AtriCure, Inc.
ATRC
$33.49
$0.732.23%
D
Sell
10/31/2024Upgraded
AtriCure, Inc. (ATRC) was upgraded to D- from E+ on 10/31/2024 due to an increase in the valuation index.
AtriCure, Inc. (ATRC) was upgraded to D- from E+ on 10/31/2024 due to an increase in the valuation index.
E
Sell
11/6/2023Downgrade
AtriCure, Inc. (ATRC) was downgraded to E+ from D on 11/6/2023 due to a major decline in the efficiency index, total return index and volatility index. Net income declined 76.92% from -$5.12M to -$9.06M, and total capital declined 0.01% from $537.26M to $537.21M.
AtriCure, Inc. (ATRC) was downgraded to E+ from D on 11/6/2023 due to a major decline in the efficiency index, total return index and volatility index. Net income declined 76.92% from -$5.12M to -$9.06M, and total capital declined 0.01% from $537.26M to $537.21M.
D
Sell
11/3/2022Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from C- on 11/3/2022 due to a major decline in the valuation index, efficiency index and growth index. Operating cash flow declined 142.18% from $4.23M to -$1.78M, total revenue declined 1.52% from $84.53M to $83.25M, and total capital declined 1.23% from $531.68M to $525.12M.
AtriCure, Inc. (ATRC) was downgraded to D from C- on 11/3/2022 due to a major decline in the valuation index, efficiency index and growth index. Operating cash flow declined 142.18% from $4.23M to -$1.78M, total revenue declined 1.52% from $84.53M to $83.25M, and total capital declined 1.23% from $531.68M to $525.12M.
C
Hold
10/31/2022Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 10/31/2022 due to an increase in the total return index and volatility index.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 10/31/2022 due to an increase in the total return index and volatility index.
D
Sell
10/14/2022Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 10/14/2022 due to a decline in the volatility index and total return index.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 10/14/2022 due to a decline in the volatility index and total return index.
C
Hold
5/5/2022Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 5/5/2022 due to a noticeable increase in the growth index and valuation index. Total revenue increased 1.85% from $73.22M to $74.58M.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 5/5/2022 due to a noticeable increase in the growth index and valuation index. Total revenue increased 1.85% from $73.22M to $74.58M.
D
Sell
2/28/2022Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 2/28/2022 due to a major decline in the growth index, volatility index and total return index. Earnings per share declined from $2.11 to -$0.3034, and EBIT declined 39.98% from -$8.93M to -$12.5M.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 2/28/2022 due to a major decline in the growth index, volatility index and total return index. Earnings per share declined from $2.11 to -$0.3034, and EBIT declined 39.98% from -$8.93M to -$12.5M.
C
Hold
11/8/2021Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 11/8/2021 due to a significant increase in the efficiency index, volatility index and growth index. Net income increased 697.55% from -$16.25M to $97.11M, earnings per share increased from -$0.3609 to $2.11, and operating cash flow increased 94.88% from -$4.53M to -$232.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 11/8/2021 due to a significant increase in the efficiency index, volatility index and growth index. Net income increased 697.55% from -$16.25M to $97.11M, earnings per share increased from -$0.3609 to $2.11, and operating cash flow increased 94.88% from -$4.53M to -$232.
D
Sell
6/9/2021Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 6/9/2021 due to a major increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.4207 to -$0.379, and total revenue increased 2.69% from $57.73M to $59.28M.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 6/9/2021 due to a major increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.4207 to -$0.379, and total revenue increased 2.69% from $57.73M to $59.28M.
D
Sell
4/9/2021Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 4/9/2021 due to a decline in the growth index and valuation index. Earnings per share declined from -$0.1124 to -$0.4207, and EBIT declined 80.78% from -$3.8M to -$6.87M.
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 4/9/2021 due to a decline in the growth index and valuation index. Earnings per share declined from -$0.1124 to -$0.4207, and EBIT declined 80.78% from -$3.8M to -$6.87M.
D
Sell
2/18/2021Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 2/18/2021 due to a significant increase in the total return index and volatility index.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 2/18/2021 due to a significant increase in the total return index and volatility index.
D
Sell
11/27/2020Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 11/27/2020 due to a decline in the valuation index.
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 11/27/2020 due to a decline in the valuation index.
D
Sell
11/12/2020Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 11/12/2020 due to a noticeable increase in the solvency index, growth index and valuation index. Operating cash flow increased 133.01% from -$11.55M to $3.81M, EBIT increased 47.85% from -$7.29M to -$3.8M, and earnings per share increased from -$0.1977 to -$0.1124.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 11/12/2020 due to a noticeable increase in the solvency index, growth index and valuation index. Operating cash flow increased 133.01% from -$11.55M to $3.81M, EBIT increased 47.85% from -$7.29M to -$3.8M, and earnings per share increased from -$0.1977 to -$0.1124.
D
Sell
5/1/2020Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 5/1/2020 due to a major decline in the efficiency index, solvency index and growth index. Operating cash flow declined 355.85% from -$3.53M to -$16.09M, total revenue declined 13.2% from $61.32M to $53.23M, and debt to equity increased from 0.25 to 0.27.
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 5/1/2020 due to a major decline in the efficiency index, solvency index and growth index. Operating cash flow declined 355.85% from -$3.53M to -$16.09M, total revenue declined 13.2% from $61.32M to $53.23M, and debt to equity increased from 0.25 to 0.27.
D
Sell
4/2/2020Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 4/2/2020 due to a large increase in the total return index and valuation index.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 4/2/2020 due to a large increase in the total return index and valuation index.
D
Sell
3/18/2020Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 3/18/2020 due to a decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.2474 to -$0.4215, EBIT declined 46.11% from -$8.88M to -$12.98M, and operating cash flow declined 36.25% from -$2.59M to -$3.53M.
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 3/18/2020 due to a decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.2474 to -$0.4215, EBIT declined 46.11% from -$8.88M to -$12.98M, and operating cash flow declined 36.25% from -$2.59M to -$3.53M.
D
Sell
12/11/2019Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 12/11/2019 due to an increase in the volatility index and total return index.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 12/11/2019 due to an increase in the volatility index and total return index.
D
Sell
11/26/2019Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 11/26/2019 due to a large decline in the solvency index, valuation index and volatility index.
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 11/26/2019 due to a large decline in the solvency index, valuation index and volatility index.
D
Sell
11/5/2019Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 11/5/2019 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 169.14% from $3.75M to -$2.59M, earnings per share declined from -$0.1098 to -$0.2474, and EBIT declined 46.92% from -$6.04M to -$8.88M.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 11/5/2019 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 169.14% from $3.75M to -$2.59M, earnings per share declined from -$0.1098 to -$0.2474, and EBIT declined 46.92% from -$6.04M to -$8.88M.
C
Hold
8/2/2019Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 8/2/2019 due to a substantial increase in the growth index, solvency index and volatility index. Operating cash flow increased 127.88% from -$13.44M to $3.75M, earnings per share increased from -$0.1524 to -$0.1098, and EBIT increased 13.5% from -$6.99M to -$6.04M.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 8/2/2019 due to a substantial increase in the growth index, solvency index and volatility index. Operating cash flow increased 127.88% from -$13.44M to $3.75M, earnings per share increased from -$0.1524 to -$0.1098, and EBIT increased 13.5% from -$6.99M to -$6.04M.
D
Sell
12/14/2018Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 12/14/2018 due to a decline in the total return index.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 12/14/2018 due to a decline in the total return index.
C
Hold
11/29/2018Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 11/29/2018 due to a noticeable increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.25 to 0.24.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 11/29/2018 due to a noticeable increase in the total return index, solvency index and volatility index. Debt to equity declined from 0.25 to 0.24.
D
Sell
10/24/2018Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 10/24/2018 due to a decline in the total return index.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 10/24/2018 due to a decline in the total return index.
C
Hold
9/19/2018Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 9/19/2018 due to a large increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.3078 to -$0.0102, operating cash flow increased 90.09% from -$9.43M to -$935, and EBIT increased 47.42% from -$9.43M to -$4.96M.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 9/19/2018 due to a large increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.3078 to -$0.0102, operating cash flow increased 90.09% from -$9.43M to -$935, and EBIT increased 47.42% from -$9.43M to -$4.96M.
D
Sell
6/20/2018Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 6/20/2018 due to a noticeable increase in the total return index and volatility index.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 6/20/2018 due to a noticeable increase in the total return index and volatility index.
D
Sell
4/30/2018Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 4/30/2018 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 717.41% from $1.53M to -$9.43M, earnings per share declined from -$0.079 to -$0.3078, and debt to equity increased from 0.15 to 0.26.
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 4/30/2018 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 717.41% from $1.53M to -$9.43M, earnings per share declined from -$0.079 to -$0.3078, and debt to equity increased from 0.15 to 0.26.
D
Sell
4/24/2018Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 4/24/2018 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 1,066.41% from $131 to $1.53M, earnings per share increased from -$0.2224 to -$0.079, and net income increased 64.39% from -$7.25M to -$2.58M.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 4/24/2018 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 1,066.41% from $131 to $1.53M, earnings per share increased from -$0.2224 to -$0.079, and net income increased 64.39% from -$7.25M to -$2.58M.
D
Sell
1/5/2018Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 1/5/2018 due to a noticeable decline in the total return index, growth index and efficiency index. EBIT declined 7.74% from -$6.36M to -$6.85M, total revenue declined 6.81% from $45.23M to $42.15M, and net income declined 5.27% from -$6.88M to -$7.25M.
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 1/5/2018 due to a noticeable decline in the total return index, growth index and efficiency index. EBIT declined 7.74% from -$6.36M to -$6.85M, total revenue declined 6.81% from $45.23M to $42.15M, and net income declined 5.27% from -$6.88M to -$7.25M.
D
Sell
10/17/2017Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 10/17/2017 due to a noticeable decline in the total return index.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 10/17/2017 due to a noticeable decline in the total return index.
C
Hold
7/28/2017Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 7/28/2017 due to a substantial increase in the growth index, total return index and efficiency index. Operating cash flow increased 88.93% from -$9.55M to -$1.06M, EBIT increased 34.09% from -$9.64M to -$6.36M, and earnings per share increased from -$0.318 to -$0.2132.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 7/28/2017 due to a substantial increase in the growth index, total return index and efficiency index. Operating cash flow increased 88.93% from -$9.55M to -$1.06M, EBIT increased 34.09% from -$9.64M to -$6.36M, and earnings per share increased from -$0.318 to -$0.2132.
D
Sell
7/6/2017Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 7/6/2017 due to a large increase in the total return index, volatility index and efficiency index.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 7/6/2017 due to a large increase in the total return index, volatility index and efficiency index.
D
Sell
1/20/2017Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 1/20/2017 due to a decline in the total return index.
AtriCure, Inc. (ATRC) was downgraded to D from D+ on 1/20/2017 due to a decline in the total return index.
D
Sell
11/9/2016Upgraded
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 11/9/2016 due to an increase in the growth index. Operating cash flow increased 117.86% from -$6.03M to $1.08M, EBIT increased 18.76% from -$7.74M to -$6.29M, and earnings per share increased from -$0.2599 to -$0.2139.
AtriCure, Inc. (ATRC) was upgraded to D+ from D on 11/9/2016 due to an increase in the growth index. Operating cash flow increased 117.86% from -$6.03M to $1.08M, EBIT increased 18.76% from -$7.74M to -$6.29M, and earnings per share increased from -$0.2599 to -$0.2139.
D
Sell
3/11/2016Downgrade
AtriCure, Inc. (ATRC) was downgraded to D from C- on 3/11/2016 due to a significant decline in the volatility index, total return index and growth index. Operating cash flow declined 255.02% from $2.63M to -$4.08M, earnings per share declined from -$0.2236 to -$0.3563, and EBIT declined 54.74% from -$5.6M to -$8.67M.
AtriCure, Inc. (ATRC) was downgraded to D from C- on 3/11/2016 due to a significant decline in the volatility index, total return index and growth index. Operating cash flow declined 255.02% from $2.63M to -$4.08M, earnings per share declined from -$0.2236 to -$0.3563, and EBIT declined 54.74% from -$5.6M to -$8.67M.
C
Hold
1/20/2016Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 1/20/2016 due to an increase in the valuation index.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 1/20/2016 due to an increase in the valuation index.
D
Sell
11/5/2015Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 11/5/2015 due to a large decline in the growth index, total return index and efficiency index. Total revenue declined 3.62% from $32.43M to $31.26M, and total capital declined 2.49% from $128.82M to $125.61M.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 11/5/2015 due to a large decline in the growth index, total return index and efficiency index. Total revenue declined 3.62% from $32.43M to $31.26M, and total capital declined 2.49% from $128.82M to $125.61M.
C
Hold
10/29/2015Downgrade
AtriCure, Inc. (ATRC) was downgraded to C- from C on 10/29/2015 due to a large decline in the volatility index, total return index and efficiency index. Net income declined 7.12% from -$5.27M to -$4.89M.
AtriCure, Inc. (ATRC) was downgraded to C- from C on 10/29/2015 due to a large decline in the volatility index, total return index and efficiency index. Net income declined 7.12% from -$5.27M to -$4.89M.
C
Hold
5/26/2015Upgraded
AtriCure, Inc. (ATRC) was upgraded to C from C- on 5/26/2015 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 345.6% from -$2.01M to -$8.97M, EBIT increased 6.75% from -$4.83M to -$5.16M, and total revenue increased 1.62% from $29.26M to $29.73M.
AtriCure, Inc. (ATRC) was upgraded to C from C- on 5/26/2015 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 345.6% from -$2.01M to -$8.97M, EBIT increased 6.75% from -$4.83M to -$5.16M, and total revenue increased 1.62% from $29.26M to $29.73M.
C
Hold
4/30/2015Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 4/30/2015 due to a noticeable increase in the total return index and volatility index.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 4/30/2015 due to a noticeable increase in the total return index and volatility index.
D
Sell
3/5/2015Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 3/5/2015 due to a decline in the total return index, volatility index and valuation index.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 3/5/2015 due to a decline in the total return index, volatility index and valuation index.
C
Hold
5/2/2014Upgraded
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 5/2/2014 due to a noticeable increase in the solvency index, valuation index and volatility index. The quick ratio increased from 1.49 to 5.87, and debt to equity declined from 0.09 to 0.
AtriCure, Inc. (ATRC) was upgraded to C- from D+ on 5/2/2014 due to a noticeable increase in the solvency index, valuation index and volatility index. The quick ratio increased from 1.49 to 5.87, and debt to equity declined from 0.09 to 0.
D
Sell
3/31/2014Downgrade
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 3/31/2014 due to a decline in the total return index and growth index. Operating cash flow declined 554.6% from $674 to -$3.06M.
AtriCure, Inc. (ATRC) was downgraded to D+ from C- on 3/31/2014 due to a decline in the total return index and growth index. Operating cash flow declined 554.6% from $674 to -$3.06M.
NASDAQ
03/14/2025 11:41AM Eastern
Quotes delayed
